Actively Recruiting
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2024-06-20
1250
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.
CONDITIONS
Official Title
Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Medical care in Nephrology department since 2015
- Histologically and cytologically documented cholangiocarcinoma, regardless of disease stage
- Hepatocellular carcinoma at any stage meeting Barcelona diagnostic criteria: tumor >1 cm on cirrhotic liver with arterial phase hyperenhancement and washout on CT or MRI
- Histologically documented hepatocellular carcinoma
You will not qualify if you...
- Lack of patient non-opposition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Serviec hépatologie-Hôpital Saint Antoine
Paris, France, 75012
Actively Recruiting
Research Team
M
Marie LEQUOY, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here